Medicinal Plants and Their Inhibitory Activities against Pancreatic Lipase: A Review

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Seyedan, Atefehalsadat ^a   Alshawsh, Mohammed Abdullah ^a   Alshagga, Mustafa Ahmed ^a,b   Koosha, Sanaz ^a   Mohamed, Zahurin ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF NOTTINGHAM MALAYSIA CAMPUS   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTHEMIS PALESTINA EXTRACT; ANTIOBESITY AGENT; ARACHIS HYPOGAEA EXTRACT; ARCTIUM LAPPA EXTRACT; BUNIUM PERSICUM EXTRACT; CASTANEA CRENATA EXTRACT; CENTELLA ASIATICA EXTRACT; CHRYSANTHEMUM CORONARIUM EXTRACT; CICHORIUM INTYBUS EXTRACT; ELEUSINE INDICA EXTRACT; ESTERASE INHIBITOR; FICUS CARICA EXTRACT; HYPERICUM TRIQUETRIFOLIUM EXTRACT; JUNIPERUS COMMUNIS EXTRACT; JUSTICIA GENDARUSSA EXTRACT; LAGERSTROEMIA INDICA EXTRACT; MALVA NICAEENSIS EXTRACT; ONONIS NATRIX EXTRACT; ORIGANUM SYRIACA EXTRACT; PARONYCHIA ARGENTEA EXTRACT; PISTACIA VERA EXTRACT; PLANT EXTRACT; POMEGRANATE EXTRACT; PORTULACA OLERACEA EXTRACT; RESEDA ALBA EXTRACT; SALVIA SPINOSA EXTRACT; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANTHEMIS PALESTINA; ARCTIUM LAPPA; ASSAY; BUNIUM PERSICUM; CASSIA; CASSIA SIAMEA; CASTANEA CRENATA; CENTELLA ASIATICA; CHICORY; CHRYSANTHEMUM; CHRYSANTHEMUM CORONARIUM; CONTROLLED STUDY; ELEUSINE INDICA; EXTRACT; FAGONIA ARABICA; FAGONIA ARABICA EXTRACT; FIG; FOOD INTAKE; HUMAN; HYPERICUM; HYPERICUM TRIQUETRIFOLIUM; JUNIPERUS; JUSTICIA GENDARUSSA; LAGERSTROEMIA; LAGERSTROEMIA INDICA; LIPID ABSORPTION; MALVA NICAEENSIS; MEDICINAL PLANT; ONONIS NATRIX; ORIGANUM SYRIACA; PARONYCHIA ARGENTEA; PEANUT; PISTACHIO; POMEGRANATE; PORTULACA OLERACEA; PRIORITY JOURNAL; RESEDA ALBA; REVIEW; SALVIA SPINOSA;

EID: 84948424884     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/973143     Document Type: Review

References (80)

1. R. Padwal, S. K. Li, and D. C. W. Lau, "Long-Term pharmacotherapy for overweight and obesity: a systematic review and meta-Analysis of randomized controlled trials, " International Journal of Obesity, vol. 27, no. 12, pp. 1437-1446, 2003.
2. C. J. Billington, L. H. Epstein, N. J. Goodwin et al. , "Overweight, obesity, and health risk, " Archives of Internal Medicine, vol. 160, no. 7, pp. 898-904, 2000.
3. E. Giovannucci, D. M. Harlan, M. C. Archer et al. , "Diabetes and cancer: a consensus report, " CA-A Cancer Journal for Clinicians, vol. 60, no. 4, pp. 207-221, 2010.
4. E. E. Calle, C. Rodriguez, K. Walker-Thurmond, and M. J. Thun, "Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults, " The New England Journal of Medicine, vol. 348, no. 17, pp. 1625-1638, 2003.
5. E. Cairns, "Obesity: the fat lady sings?" Drug Discovery Today, vol. 10, no. 5, pp. 305-307, 2005.
6. M. W. Gillman and L. Poston, Maternal Obesity, Cambridge University Press, Cambridge, UK, 2012.
7. WHO, "Obesity and overweight, " 2014, http://www. who. int/mediacentre/factsheets/fs311/en/.
8. A. H. Mokdad, J. S. Marks, D. F. Stroup, and J. L. Gerberding, "Actual causes of death in the United States, 2000, " The Journal of the American Medical Association, vol. 291, no. 10, pp. 1238-1245, 2004.
9. M. Ng, T. Fleming, M. Robinson et al. , "Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013, " The Lancet, vol. 384, no. 9945, pp. 766-781, 2014.
10. WHO, Obesity and Overweight, World Health Organization, Geneva, Switzerland, 2003.
11. J. G. Kang and C. -Y. Park, "Anti-obesity drugs: a review about their effects and safety, " Diabetes & Metabolism Journal, vol. 36, no. 1, pp. 13-25, 2012.
12. G. Glazer, "Long-Term pharmacotherapy of obesity 2000: a review of efficacy and safety, " Archives of Internal Medicine, vol. 161, no. 15, pp. 1814-1824, 2001.
13. R. Christensen, P. K. Kristensen, E. M. Bartels, H. Bliddal, and A. Astrup, "Efficacy and safety of the weight-loss drug rimonabant: a meta-Analysis of randomised trials, " The Lancet, vol. 370, no. 9600, pp. 1706-1713, 2007.
14. W. P. T. James, I. D. Caterson, W. Coutinho et al. , "Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects, "The New England Journal of Medicine, vol. 363, no. 10, pp. 905-917, 2010.
15. E. Nisoli and M. O. Carruba, "A benefit-risk assessment of sibutramine in the management of obesity, " Drug Safety, vol. 26, no. 14, pp. 1027-1048, 2003.
16. R. Guerciolini, "Mode of action of orlistat, " International Journal of Obesity and Related Metabolic Disorders, vol. 21, supplement 3, pp. S12-S23, 1997.
17. A. Ballinger and S. R. Peikin, "Orlistat: its current status as an anti-obesity drug, " European Journal of Pharmacology, vol. 440, no. 2-3, pp. 109-117, 2002.
18. P. Hadvary, H. Lengsfeld, and H. Wolfer, "Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin, " Biochemical Journal, vol. 256, no. 2, pp. 357-361, 1988.
19. S. Napier and M. Thomas, "36 Year old man presenting with pancreatitis and a history of recent commencement of orlistat case report, " Nutrition Journal, vol. 5, no. 1, article 19, 2006.
20. J. -P. Chaput, S. St-Pierre, and A. Tremblay, "Currently available drugs for the treatment of obesity: sibutramine and orlistat, " Mini-Reviews inMedicinal Chemistry, vol. 7, no. 1, pp. 3-10, 2007.
21. N. M. Neary, A. P. Goldstone, and S. R. Bloom, "Appetite regulation: fromthe gut to the hypothalamus, " Clinical Endocrinology, vol. 60, no. 2, pp. 153-160, 2004.
22. P. Chantre and D. Lairon, "Recent findings of green tea extract AR25 (exolise) and its activity for the treatment of obesity, " Phytomedicine, vol. 9, no. 1, pp. 3-8, 2002.
23. T. J. Atkinson, "Central and peripheral neuroendocrine peptides and signalling in appetite regulation: considerations for obesity pharmacotherapy, " Obesity Reviews, vol. 9, no. 2, pp. 108-120, 2008.
24. E. Naslund and P. M. Hellstrom, "Appetite signaling: from gut peptides and enteric nerves to brain, " Physiology & Behavior, vol. 92, no. 1-2, pp. 256-262, 2007.
25. K. G. Murphy and S. R. Bloom, "Gut hormones and the regulation of energy homeostasis, " Nature, vol. 444, no. 7121, pp. 854-859, 2006.
26. A. Kahler, M. Zimmermann, andW. Langhans, "Suppression of hepatic fatty acid oxidation and food intake in men, " Nutrition, vol. 15, no. 11-12, pp. 819-828, 1999.
27. M. I. Friedman, "Obesity and the hepatic control of feeding behavior, " Drug News & Perspectives, vol. 20, no. 9, pp. 573-578, 2007.
28. M. -P. St-Onge and P. J. H. Jones, "Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity, "The Journal of Nutrition, vol. 132, no. 3, pp. 329-332, 2002.
29. H. E. Bays, "Current and investigational antiobesity agents and obesity therapeutic treatment targets, " Obesity Research, vol. 12, no. 8, pp. 1197-1211, 2004.
30. T. M. Loftus, D. E. Jaworsky, C. L. Frehywot et al. , "Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors, " Science, vol. 288, no. 5475, pp. 2379-2381, 2000.
31. H. -K. Kim, M. Della-Fera, J. Lin, and C. A. Baile, "Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes, " The Journal of Nutrition, vol. 136, no. 12, pp. 2965-2969, 2006.
32. R. J. Nicolosi, T. A. Wilson, C. Lawton, and G. J. Handelman, "Dietary effects on cardiovascular disease risk factors: beyond saturated fatty acids and cholesterol, " Journal of the American College of Nutrition, vol. 20, supplement 5, pp. 421S-427S, 2001.
33. J. Hirsch and B. Batchelor, "Adipose tissue cellularity in human obesity, " Clinics in Endocrinology and Metabolism, vol. 5, no. 2, pp. 299-311, 1976.
34. S. Barcelo-Batllori and R. Gomis, "Proteomics in obesity research, " Proteomics: ClinicalApplications, vol. 3, no. 2, pp. 263-278, 2009.
35. M. I. Lefterova and M. A. Lazar, "New developments in adipogenesis, " Trends in Endocrinology & Metabolism, vol. 20, no. 3, pp. 107-114, 2009.
36. R. B. Birari andK. K. Bhutani, "Pancreatic lipase inhibitors from natural sources: unexplored potential, " Drug Discovery Today, vol. 12, no. 19-20, pp. 879-889, 2007.
37. N. A. Lunagariya, N. K. Patel, S. C. Jagtap, and K. K. Bhutani, "Inhibitors of pancreatic lipase: state of the art and clinical perspectives, " EXCLI Journal, vol. 13, pp. 897-921, 2014.
38. M. E. Lowe, "The triglyceride lipases of the pancreas, " Journal of Lipid Research, vol. 43, no. 12, pp. 2007-2016, 2002.
39. T. Tsujita, Y. Matsuura, and H. Okuda, "Studies on the inhibition of pancreatic and carboxylester lipases by protamine, " Journal of Lipid Research, vol. 37, no. 7, pp. 1481-1487, 1996.
40. T. Tsujita, H. Takaichi, T. Takaku, S. Aoyama, and J. Hiraki, "Antiobesity action of -polylysine, a potent inhibitor of pancreatic lipase, " The Journal of lipid research, vol. 47, no. 8, pp. 1852-1858, 2006.
41. M. Sumiyoshi and Y. Kimura, "Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-Term in mice, " Journal of Pharmacy and Pharmacology, vol. 58, no. 2, pp. 201-207, 2006.
42. D. Lairon, H. Lafont, J. -L. Vigne, G. Nalbone, J. Leonardi, and J. C. Hauton, "Effect of dietary fibers and cholestyramine on the activity of pancreatic lipase in vitro, " The American Journal of Clinical Nutrition, vol. 42, no. 4, pp. 629-638, 1985.
43. D. M. Roy and B. O. Schneeman, "Effect of soy protein, casein and trypsin inhibitor on cholesterol, bile acids and pancreatic enzymes in mice, " The Journal of Nutrition, vol. 111, no. 5, pp. 878-885, 1981.
44. N. G. Sahib, A. A. Hamid, D. Kitts, M. Purnama, N. Saari, and F. Abas, "Theeffects of morinda citrifolia, momordica charantia and centella asiatica extracts on lipoprotein lipase and 3t3-l1 preadipocytes, " Journal of Food Biochemistry, vol. 35, no. 4, pp. 1186-1205, 2011.
45. Y. Bustanji, M. Mohammad, M. Hudaib et al. , "Screening of some medicinal plants for their pancreatic lipase inhibitory potential, " Jordan Journal of Pharmaceutical Sciences, vol. 4, no. 2, pp. 81-88, 2011.
46. M. A. Ado, F. Abas, A. S. Mohammed, andH. M. Ghazali, "Antiand pro-lipase activity of selectedmedicinal, herbal and aquatic plants, and structure elucidation of an anti-lipase compound, " Molecules, vol. 18, no. 12, pp. 14651-14669, 2013.
47. S. Adisakwattana, J. Intrawangso, A. Hemrid, B. Chanathong, and K. Makynen, "Extracts of edible plants inhibit pancreatic lipase, cholesterol esterase and cholesterol micellization, and bind bile acids, " Food Technology and Biotechnology, vol. 50, no. 1, pp. 11-16, 2012.
48. Y. S. Kim, Y. Lee, J. Kim et al. , "Inhibitory activities of Cudrania tricuspidata leaves on pancreatic lipase in vitro and lipolysis in vivo, " Evidence-Based Complementary and AlternativeMedicine, vol. 2012, Article ID 878365, 8 pages, 2012.
49. H. -Y. Lai, S. -L. Ong, and N. K. Rao, "In vitro lipase inhibitory effect of thirty two selected plants inMalaysia, " Asian Journal of Pharmaceutical and Clinical Research, vol. 7, no. 3, 2014.
50. F. Conforti, V. Perri, F. Menichini et al. , "Wild mediterranean dietary plants as inhibitors of pancreatic lipase, " Phytotherapy Research, vol. 26, no. 4, pp. 600-604, 2012.
51. C. -D. Zheng, Y. -Q. Duan, J. -M. Gao, and Z. -G. Ruan, "Screening for anti-lipase properties of 37 traditional Chinese medicinal herbs, " Journal of the Chinese Medical Association, vol. 73, no. 6, pp. 319-324, 2010.
52. A. Toma, E. Makonnen, Y. Mekonnen, A. Debella, and S. Addisakwattana, "Intestinal alpha-glucosidase and some pancreatic enzymes inhibitory effect of hydroalcholic extract of Moringa stenopetala leaves, " BMC Complementary and Alternative Medicine, vol. 14, no. 1, article 180, 2014.
53. L. S. Teixeira, A. S. Lima, A. P. A. Boleti et al. , "Effects of Passiflora nitida Kunth leaf extract on digestive enzymes and high caloric diet in rats, " Journal of Natural Medicines, vol. 68, no. 2, pp. 316-325, 2014.
54. M. Marrelli, M. R. Loizzo, M. Nicoletti, F. Menichini, and F. Conforti, "Inhibition of key enzymes linked to obesity by preparations from Mediterranean dietary plants: effects on -Amylase and pancreatic lipase activities, " Plant Foods forHuman Nutrition, vol. 68, no. 4, pp. 340-346, 2013.
55. A. P. Ekanem, M. Wang, J. E. Simon, and D. A. Moreno, "Antiobesity properties of two African plants (Afromomum meleguetta and Spilanthes acmella) by pancreatic lipase inhibition, " Phytotherapy Research, vol. 21, no. 12, pp. 1253-1255, 2007.
56. D. Kumar, A. Karmase, S. Jagtap, R. Shekhar, and K. K. Bhutani, "Pancreatic lipase inhibitory activity of cassiamin A, a bianthraquinone from Cassia siamea, " Natural Product Communications, vol. 8, no. 2, pp. 195-198, 2013.
57. C. Roh andU. Jung, "Screening of crude plant extractswith antiobesity activity, " International Journal ofMolecular Sciences, vol. 13, no. 2, pp. 1710-1719, 2012.
58. C. Kaewpiboon, K. Lirdprapamongkol, C. Srisomsap et al. , "Studies of the in vitro cytotoxic, antioxidant, lipase inhibitory and antimicrobial activities of selected Thai medicinal plants, " BMC Complementary and Alternative Medicine, vol. 12, no. 1, article 217, 2012.
59. J. Chompoo, A. Upadhyay, S. Gima, M. Fukuta, and S. Tawata, "Antiatherogenic properties of acetone extract of Alpinia zerumbet seeds, " Molecules, vol. 17, no. 6, pp. 6237-6248, 2012.
60. T. Morikawa, S. Chaipech, H. Matsuda et al. , "Anti-hyperlipidemic constituents from the bark of Shorea roxburghii, " Journal of Natural Medicines, vol. 66, no. 3, pp. 516-524, 2012.
61. Y. M. Lee, Y. S. Kim, Y. Lee et al. , "Inhibitory activities of pancreatic lipase and phosphodiesterase from Korean medicinal plant extracts, " Phytotherapy Research, vol. 26, no. 5, pp. 778-782, 2012.
62. H. Raghavendra, N. Mallikarjun, and T. Venugopal, "Elemental composition, anticariogenic, pancreatic lipase inhibitory and cytotoxic activity of Artocarpus lakoocha Roxb pericarp, " International Journal of Drug Development and Research, vol. 4, no. 1, pp. 330-336, 2012.
63. S. P. de Souza, L. L. S. Pereira, A. A. Souza, and C. D. dos Santos, "Inhibition of pancreatic lipase by extracts of Baccharis trimera (Less. ) DC. , Asteraceae: evaluation of antinutrients and effect on glycosidases, " Revista Brasileira de Farmacognosia, vol. 21, no. 3, pp. 450-455, 2011.
64. S. A. Ivanov, K. Nomura, I. L. Malfanov, I. V. Sklyar, and L. R. Ptitsyn, "Isolation of a novel catechin from Bergenia rhizomes that has pronounced lipase-inhibiting and antioxidative properties, " Fitoterapia, vol. 82, no. 2, pp. 212-218, 2011.
65. M. Yoshikawa, H. Shimoda, N. Nishida, M. Takada, and H. Matsuda, "Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lipolytic activities have mild antiobesity effects in rats, " The Journal of Nutrition, vol. 132, no. 7, pp. 1819-1824, 2002.
66. D. A. Moreno, N. Ilic, A. Poulev, D. L. Brasaemle, S. K. Fried, and I. Raskin, "Inhibitory effects of grape seed extract on lipases, " Nutrition, vol. 19, no. 10, pp. 876-879, 2003.
67. D. A. Moreno, N. Ilic, A. Poulev, and I. Raskin, "Effects of Arachis hypogaea nutshell extract on lipid metabolic enzymes and obesity parameters, " Life Sciences, vol. 78, no. 24, pp. 2797-2803, 2006.
68. I. K. Adnyana, E. Y. Sukandar, A. Yuniarto, and S. Finna, "Anti-obesity effect of the pomegranate leaves ethanol extract (Punicagranatuml. ) in high-fat diet induced mice, " International Journal of Pharmacy and Pharmaceutical Sciences, vol. 6, no. 4, pp. 626-631, 2014.
69. S. Habtemariam, "Antihyperlipidemic components of Cassia auriculata aerial parts: identification through in vitro studies, " Phytotherapy Research, vol. 27, no. 1, pp. 152-155, 2013.
70. L. Han, W. Li, S. Narimatsu et al. , "Inhibitory effects of compounds isolated fromfruit of Juglansmandshurica on pancreatic lipase, " Journal of Natural Medicines, vol. 61, no. 2, pp. 184-186, 2007.
71. D. A. Moreno, C. Ripoll, N. Ilic, A. Poulev, C. Aubin, and I. Raskin, "Inhibition of lipid metabolic enzymes usingMangifera indica extracts, " Journal of Food, Agriculture and Environment, vol. 4, no. 1, pp. 21-26, 2006.
72. Y. Ono, E. Hattori, Y. Fukaya, S. Imai, and Y. Ohizumi, "Antiobesity effect of Nelumbo nucifera leaves extract in mice and rats, " Journal of Ethnopharmacology, vol. 106, no. 2, pp. 238-244, 2006.
73. H. Kurihara, S. Asami, H. Shibata, H. Fukami, and T. Tanaka, "Hypolipemic effect of Cyclocarya paliurus (Batal) Iljinskaja in lipid-loaded mice, " Biological and Pharmaceutical Bulletin, vol. 26, no. 3, pp. 383-385, 2003.
74. H. Y. Kim and M. H. Kang, "Screening of Korean medicinal plants for lipase inhibitory activity, " Phytotherapy Research, vol. 19, no. 4, pp. 359-361, 2005.
75. N. Sharma, V. K. Sharma, and S. -Y. Seo, "Screening of some medicinal plants for anti-lipase activity, " Journal of Ethnopharmacology, vol. 97, no. 3, pp. 453-456, 2005.
76. A. Gholamhoseinian, B. Shahouzebi, and F. Sharifi-far, "Inhibitory effect of some plant extracts on pancreatic lipase, " International Journal of Pharmacology, vol. 6, no. 1, pp. 18-24, 2010.
77. C. -S. Kwon, H. Y. Sohn, S. H. Kim et al. , "Anti-obesity effect of Dioscorea nipponica makino with lipase-inhibitory activity in rodents, " Bioscience, Biotechnology and Biochemistry, vol. 67, no. 7, pp. 1451-1456, 2003.
78. R. Mendelsohn and M. J. Balick, "The value of undiscovered pharmaceuticals in tropical forests, " Economic Botany, vol. 49, no. 2, pp. 223-228, 1995.
79. A. Ahmadiani, M. Fereidoni, S. Semnanian, M. Kamalinejad, and S. Saremi, "Antinociceptive and anti-inflammatory effects of Sambucus ebulus rhizome extract in rats, " Journal of Ethnopharmacology, vol. 61, no. 3, pp. 229-235, 1998.
80. S. A. Mitchell and M. H. Ahmad, "A review of medicinal plant research at the University of the West Indies, Jamaica, 1948-2001, " West Indian Medical Journal, vol. 55, no. 4, pp. 243-269, 2006.